Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
386M
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
9.96M
-
Shares change
-
-717K
-
Total reported value, excl. options
-
$10.3M
-
Value change
-
-$894K
-
Number of buys
-
8
-
Number of sells
-
-10
-
Price
-
$1.03
Significant Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q4 2019
25 filings reported holding TRIB - Trinity Biotech plc - Class 'A' Ordinary Shares as of Q4 2019.
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.96M shares
of 386M outstanding shares and own 2.58% of the company stock.
Largest 10 shareholders include STONEHILL CAPITAL MANAGEMENT LLC (3M shares), Paradice Investment Management LLC (1.54M shares), HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC (1.48M shares), Fondren Management LP (939K shares), RENAISSANCE TECHNOLOGIES LLC (687K shares), HEARTLAND ADVISORS INC (659K shares), FIRST WILSHIRE SECURITIES MANAGEMENT INC (530K shares), Invenomic Capital Management LP (511K shares), Adirondack Research & Management Inc. (353K shares), and MILLENNIUM MANAGEMENT LLC (158K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.